Sernova Biotherapeutics Inc SEOVF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.91M | 4.99M | 5.02M | 5.36M | 5.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.44M | 7.47M | 8.84M | 10.70M | 12.40M |
| Operating Income | -6.44M | -7.47M | -8.84M | -10.70M | -12.40M |
| Income Before Tax | -7.56M | -8.66M | -8.94M | -11.21M | -13.22M |
| Income Tax Expenses | -123.70K | -76.10K | -50.20K | 6.20K | 50.90K |
| Earnings from Continuing Operations | -7.43 | -8.59 | -8.89 | -11.21 | -13.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.43M | -8.59M | -8.89M | -11.21M | -13.27M |
| EBIT | -6.44M | -7.47M | -8.84M | -10.70M | -12.40M |
| EBITDA | -6.39M | -7.29M | -8.63M | -10.45M | -12.17M |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 1.39B | 1.34B | 1.32B | 1.31B | 1.30B |
| Average Diluted Shares Outstanding | 1.39B | 1.34B | 1.32B | 1.31B | 1.30B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |